1. Home
  2. CANF vs POLA Comparison

CANF vs POLA Comparison

Compare CANF & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$2.25

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Logo Polar Power Inc.

POLA

Polar Power Inc.

HOLD

Current Price

$1.26

Market Cap

6.0M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANF
POLA
Founded
1994
1979
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
6.0M
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
CANF
POLA
Price
$2.25
$1.26
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$50.00
N/A
AVG Volume (30 Days)
198.3K
76.3K
Earning Date
03-26-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$24,801,141.00
Revenue This Year
$2,715,455.50
N/A
Revenue Next Year
$101.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.14
52 Week Low
$0.17
$1.23
52 Week High
$10.40
$5.70

Technical Indicators

Market Signals
Indicator
CANF
POLA
Relative Strength Index (RSI) 32.90 34.36
Support Level $2.16 N/A
Resistance Level $2.39 $1.93
Average True Range (ATR) 0.12 0.06
MACD -0.02 -0.00
Stochastic Oscillator 7.96 15.37

Price Performance

Historical Comparison
CANF
POLA

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Other Asia Pacific, Europe and Middle East, United Kingdom, and South Africa.

Share on Social Networks: